MASSACHUSETTS GENERAL HOSPITAL SELECTS ELEKTA AS NEW VENDOR FOR COMPLETE CANCER TREATMENT SOLUTION

MASSACHUSETTS GENERAL HOSPITAL SELECTS ELEKTA AS NEW VENDOR FOR COMPLETE CANCER
TREATMENT SOLUTION

Largest hospital in New England orders four treatment systems

PRESS RELEASE			
Stockholm, Sweden, October 2, 2009

Massachusetts General Hospital (MGH) Cancer Center has purchased four radiation
therapy treatment systems from Elekta, including three Elekta Infinity and one
Elekta Synergy® S. The order, which includes information management software,
will enable the facility to offer patients a complete cancer treatment solution
from the company.

The three Infinity systems position MGH to take advantage of Volumetric
Modulated Arc Therapy (VMAT), a new radiation therapy technique that allows
clinicians to deliver tightly focused radiation treatments in less time. A
treatment session typically can be conducted in five minutes or less and
delivered with single or multiple arcs depending upon the patients needs.

Elekta Infinity also supports all forms of Intensity Modulated Radiation Therapy
(IMRT) and Image Guided Radiation Therapy (IGRT).

MGH also purchased Elekta Synergy S, a state-of-the-art digital linear
accelerator with integrated imaging capabilities. The facility will use Elekta
Synergy S to perform Stereotactic Radiosurgery (SRS) and Stereotactic
Radiotherapy (SRT) throughout the body, as well as hypofractionated treatments
utilizing IGRT and VMAT.

The four treatment machines also feature the HexaPOD™ evo RT system, a vision
guided patient positioning platform with six degrees of freedom. Six degrees of
freedom means that the system can detect and correct misalignments in patient
positioning —making it ideal for the very high accuracy required during critical
radiation treatments.

For further information, please contact:

Stina Thorman, Investor Relations, Elekta AB
Tel: +46 8 587 254 37, +46 70 778 60 10, e-mail: stina.thorman@elekta.com  

Michelle Lee, Director, Marketing Services, Elekta Inc. 
Tel: +1 770-670-2447, e-mail: michelle.lee@elekta.com

About Elekta

Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated state of the art tools and treatment planning systems for
radiation therapy and radiosurgery, as well as workflow enhancing software
systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent and
resource-efficient solutions that offer confidence to both healthcare providers
and patients, Elekta aims to improve, prolong and even save patient lives,
making the future possible today.

Today, Elekta solutions in oncology and neurosurgery are used in over 5,000
hospitals globally, and every day more than 100,000 patients receive diagnosis,
treatment or follow-up with the help of a solution from the Elekta Group.

Elekta employs around 2,500 employees globally. The corporate headquarter is
located in Stockholm, Sweden, and the company is listed on the Nordic Exchange
under the ticker EKTAb. For more information about Elekta, please visit
www.elekta.com.